Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| LOEWS CORPL · Entity 3231 | DIRECTOR EMERITUS | June 30, 2026 | July 01, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
LOEWS CORP
Report date June 30, 2026 · Filed July 01, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 22,165 |
Reported balance
After 2026-06-30 transaction · row 1
1 source rowRow 1 · 2026-06-30 · Grant · Acquired 102 · Balance 22,165 F1: Represents quarterly grant of common stock in respect of director compensation (prorated for service through the date of his retirement as a director) under the Loews Corporation 2025 Incentive Compensation Plan. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents quarterly grant of common stock in respect of director compensation (prorated for service through the date of his retirement as a director) under the Loews Corporation 2025 Incentive Compensation Plan.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
CANTEL MEDICAL CORP
Report date June 02, 2021 · Filed June 02, 2021
Section 16 reporting ended · disclosed 2021-06-02. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, par value $.10 per shareSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2021-06-02 transaction · row 1
1 source rowRow 1 · 2021-06-02 · Disposition to issuer · Disposed 2,865,637 · Balance 0 F1: Represents (i) a portion of shares that, at the effective time of the First Merger (as defined in the Agreement and Plan of Merger, as amended and restated on March 1, 2021 (the "Merger Agreement"), by and among Cantel Medical Corp., a Delaware corporation (the "Company"), STERIS plc, an Irish public limited company ("STERIS"), Solar New US Holding Co, LLC and Crystal Merger Sub 1, LLC) (the "Effective Time"), were converted into the right to receive (i) 0.33787 ordinary shares, par value $0.001 per share, of STERIS (the "Stock Consideration"), and (ii) $16.93 in cash (the "Cash Consideration" and, together with the Stock Consideration, the "Merger Consideration"). F2: Based on the closing price of ordinary shares of STERIS on June 1, 2021, the last trading day before the Effective Time, the value of the Stock Consideration payable per share of common stock, par value $.10 per share, of the Company ("Company Common Stock") was $63.66, and the value of the Merger Consideration payable per share of Company Common Stock pursuant to the Merger Agreement was $80.59 and (ii) a portion of shares that, at the Effective Time, were converted into STERIS equity awards based on an equity award exchange ratio that is intended to preserve the value of the award immediately before and after the conversion. |
| Common Stock, par value $.10 per shareSEC Table I · non-derivative | IndirectBy wife | 0 |
Reported balance
After 2021-06-02 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2021-06-02 · Disposition to issuer · Disposed 374,112 · Balance 0 F1: Represents (i) a portion of shares that, at the effective time of the First Merger (as defined in the Agreement and Plan of Merger, as amended and restated on March 1, 2021 (the "Merger Agreement"), by and among Cantel Medical Corp., a Delaware corporation (the "Company"), STERIS plc, an Irish public limited company ("STERIS"), Solar New US Holding Co, LLC and Crystal Merger Sub 1, LLC) (the "Effective Time"), were converted into the right to receive (i) 0.33787 ordinary shares, par value $0.001 per share, of STERIS (the "Stock Consideration"), and (ii) $16.93 in cash (the "Cash Consideration" and, together with the Stock Consideration, the "Merger Consideration"). F2: Based on the closing price of ordinary shares of STERIS on June 1, 2021, the last trading day before the Effective Time, the value of the Stock Consideration payable per share of common stock, par value $.10 per share, of the Company ("Company Common Stock") was $63.66, and the value of the Merger Consideration payable per share of Company Common Stock pursuant to the Merger Agreement was $80.59 and (ii) a portion of shares that, at the Effective Time, were converted into STERIS equity awards based on an equity award exchange ratio that is intended to preserve the value of the award immediately before and after the conversion. |
| Common Stock, par value $.10 per shareSEC Table I · non-derivative | IndirectBy custodial accounts for benefit of grandchildren | 0 |
Reported balance
After 2021-06-02 transaction · row 3
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 3 · 2021-06-02 · Disposition to issuer · Disposed 185,928 · Balance 0 F1: Represents (i) a portion of shares that, at the effective time of the First Merger (as defined in the Agreement and Plan of Merger, as amended and restated on March 1, 2021 (the "Merger Agreement"), by and among Cantel Medical Corp., a Delaware corporation (the "Company"), STERIS plc, an Irish public limited company ("STERIS"), Solar New US Holding Co, LLC and Crystal Merger Sub 1, LLC) (the "Effective Time"), were converted into the right to receive (i) 0.33787 ordinary shares, par value $0.001 per share, of STERIS (the "Stock Consideration"), and (ii) $16.93 in cash (the "Cash Consideration" and, together with the Stock Consideration, the "Merger Consideration"). F2: Based on the closing price of ordinary shares of STERIS on June 1, 2021, the last trading day before the Effective Time, the value of the Stock Consideration payable per share of common stock, par value $.10 per share, of the Company ("Company Common Stock") was $63.66, and the value of the Merger Consideration payable per share of Company Common Stock pursuant to the Merger Agreement was $80.59 and (ii) a portion of shares that, at the Effective Time, were converted into STERIS equity awards based on an equity award exchange ratio that is intended to preserve the value of the award immediately before and after the conversion. |
| Common Stock, par value $.10 per shareSEC Table I · non-derivative | IndirectShares held by Dico Group, Inc. | 0 |
Reported balance
After 2021-06-02 transaction · row 4
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 4 · 2021-06-02 · Disposition to issuer · Disposed 29,430 · Balance 0 F1: Represents (i) a portion of shares that, at the effective time of the First Merger (as defined in the Agreement and Plan of Merger, as amended and restated on March 1, 2021 (the "Merger Agreement"), by and among Cantel Medical Corp., a Delaware corporation (the "Company"), STERIS plc, an Irish public limited company ("STERIS"), Solar New US Holding Co, LLC and Crystal Merger Sub 1, LLC) (the "Effective Time"), were converted into the right to receive (i) 0.33787 ordinary shares, par value $0.001 per share, of STERIS (the "Stock Consideration"), and (ii) $16.93 in cash (the "Cash Consideration" and, together with the Stock Consideration, the "Merger Consideration"). F2: Based on the closing price of ordinary shares of STERIS on June 1, 2021, the last trading day before the Effective Time, the value of the Stock Consideration payable per share of common stock, par value $.10 per share, of the Company ("Company Common Stock") was $63.66, and the value of the Merger Consideration payable per share of Company Common Stock pursuant to the Merger Agreement was $80.59 and (ii) a portion of shares that, at the Effective Time, were converted into STERIS equity awards based on an equity award exchange ratio that is intended to preserve the value of the award immediately before and after the conversion. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents (i) a portion of shares that, at the effective time of the First Merger (as defined in the Agreement and Plan of Merger, as amended and restated on March 1, 2021 (the "Merger Agreement"), by and among Cantel Medical Corp., a Delaware corporation (the "Company"), STERIS plc, an Irish public limited company ("STERIS"), Solar New US Holding Co, LLC and Crystal Merger Sub 1, LLC) (the "Effective Time"), were converted into the right to receive (i) 0.33787 ordinary shares, par value $0.001 per share, of STERIS (the "Stock Consideration"), and (ii) $16.93 in cash (the "Cash Consideration" and, together with the Stock Consideration, the "Merger Consideration").
F2: Based on the closing price of ordinary shares of STERIS on June 1, 2021, the last trading day before the Effective Time, the value of the Stock Consideration payable per share of common stock, par value $.10 per share, of the Company ("Company Common Stock") was $63.66, and the value of the Merger Consideration payable per share of Company Common Stock pursuant to the Merger Agreement was $80.59 and (ii) a portion of shares that, at the Effective Time, were converted into STERIS equity awards based on an equity award exchange ratio that is intended to preserve the value of the award immediately before and after the conversion.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 11, 2021 Filed May 12, 2021 15:07 UTC | LOEWS CORP L · Entity 3231 | GrantRestricted Stock Units · Derivative | 1,725 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-21-009642 · doc1.xml · derivative · entry 2 DIKER CHARLES M · CIK 0000905400 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,725 Underlying: Common Stock · 1,725 shares Expires not disclosed F2 · security: Each RSU represents a contingent right to receive one share of the Issuer's common stock. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. F3 · derivative.exercise_date: The RSUs vest on May 11, 2022. Shares of the Issuer's common stock will be delivered to the Reporting Person upon vesting, subject to any election to defer delivery of shares made by the Reporting Person. F3 · derivative.expiration_date: The RSUs vest on May 11, 2022. Shares of the Issuer's common stock will be delivered to the Reporting Person upon vesting, subject to any election to defer delivery of shares made by the Reporting Person. Read SEC document |
| March 01, 2021 Filed Mar 2, 2021 19:38 UTC | LOEWS CORP L · Entity 3231 | Exercise / conversionStock Appreciation Right · Derivative | 1,500 | $0.00 Strike: $43.14 | $0.00 |
DisclosureSEC source: 0001567619-21-005284 · doc1.xml · derivative · entry 4 DIKER CHARLES M · CIK 0000905400 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,500 shares Expires 2021-03-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: The Reporting Person received the Derivative Security pursuant to a stock appreciation right grant at no cost. Read SEC document |
| March 01, 2021 Filed Mar 2, 2021 19:38 UTC | LOEWS CORP L · Entity 3231 | SaleCommon Stock | 170 | $49.36 | $8,391.20 |
DisclosureSEC source: 0001567619-21-005284 · doc1.xml · nonDerivative · entry 3 DIKER CHARLES M · CIK 0000905400 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,616 F1 · price: Represents the weighted average price of multiple transactions with a range of prices between $48.62 and $49.40. The Reporting Person, upon request by the Commission Staff, the Issuer or a security holder of the Issuer, undertakes to provide further information regarding the number of securities at each separate price sold. Read SEC document |
| March 01, 2021 Filed Mar 2, 2021 19:38 UTC | LOEWS CORP L · Entity 3231 | Disposition to issuerCommon Stock | 1,330 | $48.62 | $64,664.60 |
DisclosureSEC source: 0001567619-21-005284 · doc1.xml · nonDerivative · entry 2 DIKER CHARLES M · CIK 0000905400 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,786 Read SEC document |
| March 01, 2021 Filed Mar 2, 2021 19:38 UTC | LOEWS CORP L · Entity 3231 | Exercise / conversionCommon Stock | 1,500 | $43.14 | $64,710.00 |
DisclosureSEC source: 0001567619-21-005284 · doc1.xml · nonDerivative · entry 1 DIKER CHARLES M · CIK 0000905400 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,116 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 28, 2020 Filed Jan 22, 2021 15:55 UTC | CANTEL MEDICAL CORP CMD · Entity 138805 | GiftCommon Stock, par value $.10 per share | 1,854 | $0.00 | $0.00 |
DisclosureSEC source: 0000019446-21-000004 · wf-form4_161134889542086.xml · nonDerivative · entry 3 DIKER CHARLES M · CIK 0000905400 · Director · Chairman 10b5-1 filing: Not disclosed Ownership: Indirect · By custodial accounts for benefit of grandchildren Disclosed balance after: 185,928 F1 · date: Due to processing, some of these gifts, while initiated on December 28, 2020, were not fully effected by the financial institution until December 29, 2020. Read SEC document |
| December 28, 2020 Filed Jan 22, 2021 15:55 UTC | CANTEL MEDICAL CORP CMD · Entity 138805 | GiftCommon Stock, par value $.10 per share | 1,850 | $0.00 | $0.00 |
DisclosureSEC source: 0000019446-21-000004 · wf-form4_161134889542086.xml · nonDerivative · entry 2 DIKER CHARLES M · CIK 0000905400 · Director · Chairman 10b5-1 filing: Not disclosed Ownership: Indirect · By wife Disclosed balance after: 374,112 F1 · date: Due to processing, some of these gifts, while initiated on December 28, 2020, were not fully effected by the financial institution until December 29, 2020. Read SEC document |
| December 28, 2020 Filed Jan 22, 2021 15:55 UTC | CANTEL MEDICAL CORP CMD · Entity 138805 | GiftCommon Stock, par value $.10 per share | 1,850 | $0.00 | $0.00 |
DisclosureSEC source: 0000019446-21-000004 · wf-form4_161134889542086.xml · nonDerivative · entry 1 DIKER CHARLES M · CIK 0000905400 · Director · Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,865,637 F1 · date: Due to processing, some of these gifts, while initiated on December 28, 2020, were not fully effected by the financial institution until December 29, 2020. Read SEC document |
| December 01, 2020 Filed Dec 2, 2020 16:23 UTC | LOEWS CORP L · Entity 3231 | Exercise / conversionStock Appreciation Right · Derivative | 1,500 | $0.00 Strike: $38.99 | $0.00 |
DisclosureSEC source: 0001567619-20-020529 · doc1.xml · derivative · entry 4 DIKER CHARLES M · CIK 0000905400 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,500 shares Expires 2020-12-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: The Reporting Person received the Derivative Security pursuant to a stock appreciation right grant at no cost. Read SEC document |
| December 01, 2020 Filed Dec 2, 2020 16:23 UTC | LOEWS CORP L · Entity 3231 | SaleCommon Stock | 139 | $43.05 | $5,983.95 |
DisclosureSEC source: 0001567619-20-020529 · doc1.xml · nonDerivative · entry 3 DIKER CHARLES M · CIK 0000905400 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,616 F1 · price: Represents the weighted average price of multiple transactions with a range of prices between $42.96 and $43.06. The Reporting Person, upon request by the Commission Staff, the Issuer or a security holder of the Issuer, undertakes to provide further information regarding the number of securities at each separate price sold. Read SEC document |
| December 01, 2020 Filed Dec 2, 2020 16:23 UTC | LOEWS CORP L · Entity 3231 | Disposition to issuerCommon Stock | 1,361 | $42.96 | $58,468.56 |
DisclosureSEC source: 0001567619-20-020529 · doc1.xml · nonDerivative · entry 2 DIKER CHARLES M · CIK 0000905400 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,755 Read SEC document |
| December 01, 2020 Filed Dec 2, 2020 16:23 UTC | LOEWS CORP L · Entity 3231 | Exercise / conversionCommon Stock | 1,500 | $38.99 | $58,485.00 |
DisclosureSEC source: 0001567619-20-020529 · doc1.xml · nonDerivative · entry 1 DIKER CHARLES M · CIK 0000905400 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,116 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 23, 2020 Filed Oct 27, 2020 15:00 UTC | CANTEL MEDICAL CORP CMD · Entity 138805 | GiftCommon Stock, par value $.10 per share | 94,340 | $0.00 | $0.00 |
DisclosureSEC source: 0000019446-20-000104 · wf-form4_160382520594086.xml · nonDerivative · entry 3 DIKER CHARLES M · CIK 0000905400 · Director · Chairman 10b5-1 filing: Not disclosed Ownership: Indirect · By custodial accounts for benefit of grandchildren Disclosed balance after: 184,074 Read SEC document |
| October 23, 2020 Filed Oct 27, 2020 15:00 UTC | CANTEL MEDICAL CORP CMD · Entity 138805 | GiftCommon Stock, par value $.10 per share | 72,226 | $0.00 | $0.00 |
DisclosureSEC source: 0000019446-20-000104 · wf-form4_160382520594086.xml · nonDerivative · entry 2 DIKER CHARLES M · CIK 0000905400 · Director · Chairman 10b5-1 filing: Not disclosed Ownership: Indirect · By wife Disclosed balance after: 375,962 F1 · date: Due to processing, some of these gifts, while initiated on October 23, 2020, were not fully effected by the financial institution until October 26, 2020. Read SEC document |
| October 23, 2020 Filed Oct 27, 2020 15:00 UTC | CANTEL MEDICAL CORP CMD · Entity 138805 | GiftCommon Stock, par value $.10 per share | 146,642 | $0.00 | $0.00 |
DisclosureSEC source: 0000019446-20-000104 · wf-form4_160382520594086.xml · nonDerivative · entry 1 DIKER CHARLES M · CIK 0000905400 · Director · Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,865,307 F1 · date: Due to processing, some of these gifts, while initiated on October 23, 2020, were not fully effected by the financial institution until October 26, 2020. Read SEC document |
| October 10, 2020 Filed Oct 13, 2020 17:23 UTC | CANTEL MEDICAL CORP CMD · Entity 138805 | Tax withholdingCommon Stock, par value $.10 per share | 454 | $47.36 | $21,501.44 |
DisclosureSEC source: 0000019446-20-000098 · wf-form4_160262417124588.xml · nonDerivative · entry 1 DIKER CHARLES M · CIK 0000905400 · Director · Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,011,949 F1 · shares: This represents shares withheld for taxes attributable to vesting of time-based RSUs that vested on 10/10/2020. Read SEC document |
| October 07, 2020 Filed Oct 9, 2020 14:48 UTC | CANTEL MEDICAL CORP CMD · Entity 138805 | GrantCommon Stock, par value $.10 per share | 1,695 | $0.00 | $0.00 |
DisclosureSEC source: 0000019446-20-000084 · wf-form4_160226930827458.xml · nonDerivative · entry 1 DIKER CHARLES M · CIK 0000905400 · Director · Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,012,403 F1 · shares: This represents time-based Restricted Stock Units granted on 10/7/20 that vest in three equal annual installments commencing on the first anniversary of the grant date. Read SEC document |
| June 01, 2020 Filed Jun 2, 2020 19:20 UTC | LOEWS CORP L · Entity 3231 | Exercise / conversionStock Appreciation Right · Derivative | 1,500 | $0.00 Strike: $33.12 | $0.00 |
DisclosureSEC source: 0001567619-20-011502 · doc1.xml · derivative · entry 4 DIKER CHARLES M · CIK 0000905400 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,500 shares Expires 2020-06-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Reporting Person received the Derivative Security pursuant to a stock appreciation right grant at no cost. Read SEC document |
| June 01, 2020 Filed Jun 2, 2020 19:20 UTC | LOEWS CORP L · Entity 3231 | SaleCommon Stock | 12 | $33.37 | $400.44 |
DisclosureSEC source: 0001567619-20-011502 · doc1.xml · nonDerivative · entry 3 DIKER CHARLES M · CIK 0000905400 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,616 Read SEC document |
| June 01, 2020 Filed Jun 2, 2020 19:20 UTC | LOEWS CORP L · Entity 3231 | Disposition to issuerCommon Stock | 1,488 | $33.37 | $49,654.56 |
DisclosureSEC source: 0001567619-20-011502 · doc1.xml · nonDerivative · entry 2 DIKER CHARLES M · CIK 0000905400 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,628 Read SEC document |
| June 01, 2020 Filed Jun 2, 2020 19:20 UTC | LOEWS CORP L · Entity 3231 | Exercise / conversionCommon Stock | 1,500 | $33.12 | $49,680.00 |
DisclosureSEC source: 0001567619-20-011502 · doc1.xml · nonDerivative · entry 1 DIKER CHARLES M · CIK 0000905400 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,116 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 14, 2020 Filed May 14, 2020 12:35 UTC | LOEWS CORP L · Entity 3231 | Exercise / conversionRestricted Stock Units · Derivative | 1,979 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001567619-20-009920 · doc1.xml · derivative · entry 3 DIKER CHARLES M · CIK 0000905400 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,979 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. F4 · derivative.exercise_date: As previously reported on Table II of a Form 4 filed in connection therewith, on May 14, 2019, the Reporting Person was granted 1,979 RSUs which vested on the first anniversary of the grant date. The common stock into which such vested RSUs converted is reported on Table I of this Form 4. F4 · derivative.expiration_date: As previously reported on Table II of a Form 4 filed in connection therewith, on May 14, 2019, the Reporting Person was granted 1,979 RSUs which vested on the first anniversary of the grant date. The common stock into which such vested RSUs converted is reported on Table I of this Form 4. Read SEC document |
| May 14, 2020 Filed May 14, 2020 12:35 UTC | LOEWS CORP L · Entity 3231 | Exercise / conversionCommon Stock | 1,979 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-20-009920 · doc1.xml · nonDerivative · entry 1 DIKER CHARLES M · CIK 0000905400 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,616 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · acquired: Represents the conversion into common stock upon vesting of previously awarded restricted stock units ("RSUs"). Read SEC document |
| May 12, 2020 Filed May 14, 2020 12:35 UTC | LOEWS CORP L · Entity 3231 | GrantRestricted Stock Units · Derivative | 3,292 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001567619-20-009920 · doc1.xml · derivative · entry 2 DIKER CHARLES M · CIK 0000905400 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,292 Underlying: Common Stock · 3,292 shares Expires not disclosed F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. F3 · derivative.exercise_date: The RSUs vest on May 12, 2021, and shares of the Issuer's common stock will be delivered to the Reporting Person upon vesting, subject to any election to defer delivery of shares made by the Reporting Person. F3 · derivative.expiration_date: The RSUs vest on May 12, 2021, and shares of the Issuer's common stock will be delivered to the Reporting Person upon vesting, subject to any election to defer delivery of shares made by the Reporting Person. Read SEC document |
| March 02, 2020 Filed Mar 5, 2020 18:56 UTC | LOEWS CORP L · Entity 3231 | Exercise / conversionStock Appreciation Right · Derivative | 1,500 | $0.00 Strike: $37.26 | $0.00 |
DisclosureSEC source: 0001567619-20-005710 · doc1.xml · derivative · entry 4 DIKER CHARLES M · CIK 0000905400 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,500 shares Expires 2020-03-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: The Reporting Person received the Derivative Security pursuant to a stock appreciation right grant at no cost. Read SEC document |
| March 02, 2020 Filed Mar 5, 2020 18:56 UTC | LOEWS CORP L · Entity 3231 | SaleCommon Stock | 322 | $47.46 | $15,282.12 |
DisclosureSEC source: 0001567619-20-005710 · doc1.xml · nonDerivative · entry 3 DIKER CHARLES M · CIK 0000905400 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,637 F1 · price: Represents the weighted average price of multiple transactions with a range of prices between $45.67 and $47.64. The Reporting Person, upon request by the Commission Staff, the Issuer or a security holder of the Issuer, undertakes to provide further information regarding the number of securities at each separate price sold. Read SEC document |
| March 02, 2020 Filed Mar 5, 2020 18:56 UTC | LOEWS CORP L · Entity 3231 | Disposition to issuerCommon Stock | 1,178 | $47.44 | $55,884.32 |
DisclosureSEC source: 0001567619-20-005710 · doc1.xml · nonDerivative · entry 2 DIKER CHARLES M · CIK 0000905400 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,959 Read SEC document |
| March 02, 2020 Filed Mar 5, 2020 18:56 UTC | LOEWS CORP L · Entity 3231 | Exercise / conversionCommon Stock | 1,500 | $37.26 | $55,890.00 |
DisclosureSEC source: 0001567619-20-005710 · doc1.xml · nonDerivative · entry 1 DIKER CHARLES M · CIK 0000905400 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,137 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 18, 2019 Filed Jul 31, 2020 16:41 UTC | CANTEL MEDICAL CORP CMD · Entity 138805 | GiftCommon Stock, par value $.10 per share | 1,600 | $0.00 | $0.00 |
DisclosureSEC source: 0000019446-20-000038 · wf-form4_159622807455934.xml · nonDerivative · entry 3 DIKER CHARLES M · CIK 0000905400 · Director · Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By custodial accounts for benefit of grandchildren Disclosed balance after: 89,734 Read SEC document |
| December 18, 2019 Filed Jul 31, 2020 16:41 UTC | CANTEL MEDICAL CORP CMD · Entity 138805 | GiftCommon Stock, par value $.10 per share | 2,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000019446-20-000038 · wf-form4_159622807455934.xml · nonDerivative · entry 2 DIKER CHARLES M · CIK 0000905400 · Director · Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By wife Disclosed balance after: 448,188 Read SEC document |
| December 18, 2019 Filed Jul 31, 2020 16:41 UTC | CANTEL MEDICAL CORP CMD · Entity 138805 | GiftCommon Stock, par value $.10 per share | 2,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000019446-20-000038 · wf-form4_159622807455934.xml · nonDerivative · entry 1 DIKER CHARLES M · CIK 0000905400 · Director · Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,010,708 Read SEC document |
| December 02, 2019 Filed Dec 3, 2019 17:27 UTC | LOEWS CORP L · Entity 3231 | Exercise / conversionStock Appreciation Right · Derivative | 1,500 | $0.00 Strike: $36.45 | $0.00 |
DisclosureSEC source: 0001567619-19-022517 · doc1.xml · derivative · entry 4 DIKER CHARLES M · CIK 0000905400 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,500 shares Expires 2019-12-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: The Reporting Person received the Derivative Security pursuant to a stock appreciation right grant at no cost. Read SEC document |
| December 02, 2019 Filed Dec 3, 2019 17:27 UTC | LOEWS CORP L · Entity 3231 | SaleCommon Stock | 428 | $50.40 | $21,571.20 |
DisclosureSEC source: 0001567619-19-022517 · doc1.xml · nonDerivative · entry 3 DIKER CHARLES M · CIK 0000905400 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,637 F1 · price: Represents the weighted average price of multiple transactions with a range of prices between $50.39 and $50.97. The Reporting Person, upon request by the Commission Staff, the Issuer or a security holder of the Issuer, undertakes to provide further information regarding the number of securities at each separate price sold. Read SEC document |
| December 02, 2019 Filed Dec 3, 2019 17:27 UTC | LOEWS CORP L · Entity 3231 | Disposition to issuerCommon Stock | 1,072 | $50.97 | $54,639.84 |
DisclosureSEC source: 0001567619-19-022517 · doc1.xml · nonDerivative · entry 2 DIKER CHARLES M · CIK 0000905400 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,065 Read SEC document |
| December 02, 2019 Filed Dec 3, 2019 17:27 UTC | LOEWS CORP L · Entity 3231 | Exercise / conversionCommon Stock | 1,500 | $36.45 | $54,675.00 |
DisclosureSEC source: 0001567619-19-022517 · doc1.xml · nonDerivative · entry 1 DIKER CHARLES M · CIK 0000905400 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,137 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 23, 2019 Filed Oct 24, 2019 18:58 UTC | CANTEL MEDICAL CORP CMD · Entity 138805 | SaleCommon Stock, par value $.10 per share | 4,000 | $70.80 | $283,202.00 |
DisclosureSEC source: 0001628280-19-012547 · wf-form4_157195786978650.xml · nonDerivative · entry 2 DIKER CHARLES M · CIK 0000905400 · Director · Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,012,708 F2 · price: This transaction was executed in multiple trades at prices ranging from $70.494 to $71.038. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| October 22, 2019 Filed Oct 24, 2019 18:58 UTC | CANTEL MEDICAL CORP CMD · Entity 138805 | SaleCommon Stock, par value $.10 per share | 4,000 | $70.86 | $283,453.20 |
DisclosureSEC source: 0001628280-19-012547 · wf-form4_157195786978650.xml · nonDerivative · entry 1 DIKER CHARLES M · CIK 0000905400 · Director · Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,016,708 F1 · price: This transaction was executed in multiple trades at prices ranging from $70.575 to $71.20. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| October 18, 2019 Filed Oct 21, 2019 19:39 UTC | CANTEL MEDICAL CORP CMD · Entity 138805 | Tax withholdingCommon Stock, par value $.10 per share | 538 | $72.17 | $38,827.46 |
DisclosureSEC source: 0001628280-19-012448 · wf-form4_157170112583625.xml · nonDerivative · entry 1 DIKER CHARLES M · CIK 0000905400 · Director · Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,020,708 F1 · shares: This represents shares withheld for taxes attributable to vesting of Restricted Stock Awards. Read SEC document |
| October 10, 2019 Filed Oct 15, 2019 11:21 UTC | CANTEL MEDICAL CORP CMD · Entity 138805 | Tax withholdingCommon Stock, par value $.10 per share | 330 | $68.89 | $22,733.70 |
DisclosureSEC source: 0000019446-19-000064 · edgar.xml · nonDerivative · entry 2 DIKER CHARLES M · CIK 0000905400 · Director · Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,021,246 F2 · shares: This represents shares withheld for taxes attributable to the vesting of Restricted Stock Awards and/or Restricted Stock Units. Read SEC document |
| October 10, 2019 Filed Oct 15, 2019 11:21 UTC | CANTEL MEDICAL CORP CMD · Entity 138805 | GrantCommon Stock, par value $.10 per share | 1,090 | $0.00 | $0.00 |
DisclosureSEC source: 0000019446-19-000064 · edgar.xml · nonDerivative · entry 1 DIKER CHARLES M · CIK 0000905400 · Director · Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,021,576 F1 · shares: This represents time-based Restricted Stock Units granted on 10/10/19 that vest in three equal annual installments commencing on the first anniversary of the grant date. Read SEC document |
| October 10, 2019 Filed Oct 29, 2020 12:58 UTC Amendment | CANTEL MEDICAL CORP CMD · Entity 138805 | Tax withholdingCommon Stock, par value $.10 per share | 330 | $68.89 | $22,733.70 |
DisclosureSEC source: 0000019446-20-000106 · wf-form4a_160399066635730.xml · nonDerivative · entry 2 DIKER CHARLES M · CIK 0000905400 · Director · Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,023,426 F3 · shares: This represents shares withheld for taxes attributable to vesting of Restricted Stock Awards or Restricted Stock Units. Read SEC document |
| October 10, 2019 Filed Oct 29, 2020 12:58 UTC Amendment | CANTEL MEDICAL CORP CMD · Entity 138805 | GrantCommon Stock, par value $.10 per share | 1,090 | $0.00 | $0.00 |
DisclosureSEC source: 0000019446-20-000106 · wf-form4a_160399066635730.xml · nonDerivative · entry 1 DIKER CHARLES M · CIK 0000905400 · Director · Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,023,756 F1 · shares: This represents time-based Restricted Stock Units granted on 10/10/19 that vest in three equal annual installments commencing on the first anniversary of the grant date. F2 · balance_after: This form has been amended to correct the amount of securities beneficially owned following the reported transaction, which was misreported as a result of an administrative error. Read SEC document |
| September 24, 2019 Filed Sep 26, 2019 17:26 UTC | CANTEL MEDICAL CORP CMD · Entity 138805 | Exercise / conversionOption (Right to buy) · Derivative | 25,000 | $0.00 Strike: $36.70 | $0.00 |
DisclosureSEC source: 0000019446-19-000055 · edgar.xml · derivative · entry 7 DIKER CHARLES M · CIK 0000905400 · Director · Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, par value, $.10 per share · 25,000 shares Expires 2019-10-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: This stock option, granted under the Issuer's 2006 Equity Incentive Plan, was exercisable in three equal annual installments commencing on the first anniversary of the grant date. Read SEC document |
| September 24, 2019 Filed Sep 26, 2019 17:26 UTC | CANTEL MEDICAL CORP CMD · Entity 138805 | Tax withholdingCommon Stock, par value $.10 per share | 5,265 | $79.38 | $417,935.70 |
DisclosureSEC source: 0000019446-19-000055 · edgar.xml · nonDerivative · entry 3 DIKER CHARLES M · CIK 0000905400 · Director · Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,022,666 Read SEC document |
| September 24, 2019 Filed Sep 26, 2019 17:26 UTC | CANTEL MEDICAL CORP CMD · Entity 138805 | Tax withholdingCommon Stock, par value $.10 per share | 11,559 | $79.38 | $917,553.42 |
DisclosureSEC source: 0000019446-19-000055 · edgar.xml · nonDerivative · entry 2 DIKER CHARLES M · CIK 0000905400 · Director · Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,027,931 Read SEC document |
| September 24, 2019 Filed Sep 26, 2019 17:26 UTC | CANTEL MEDICAL CORP CMD · Entity 138805 | Exercise / conversionCommon Stock, par value $.10 per share | 25,000 | $36.70 | $917,500.00 |
DisclosureSEC source: 0000019446-19-000055 · edgar.xml · nonDerivative · entry 1 DIKER CHARLES M · CIK 0000905400 · Director · Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,039,490 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 03, 2019 Filed Sep 4, 2019 18:38 UTC | LOEWS CORP L · Entity 3231 | Exercise / conversionStock Appreciation Right · Derivative | 1,500 | $0.00 Strike: $34.64 | $0.00 |
DisclosureSEC source: 0001567619-19-017852 · doc1.xml · derivative · entry 4 DIKER CHARLES M · CIK 0000905400 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,500 shares Expires 2019-09-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: The Reporting Person received the Derivative Security pursuant to a stock appreciation right grant at no cost. Read SEC document |
| September 03, 2019 Filed Sep 4, 2019 18:38 UTC | LOEWS CORP L · Entity 3231 | SaleCommon Stock | 411 | $47.72 | $19,612.92 |
DisclosureSEC source: 0001567619-19-017852 · doc1.xml · nonDerivative · entry 3 DIKER CHARLES M · CIK 0000905400 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,637 F1 · price: Represents the weighted average price of multiple transactions with a range of prices between $47.68 and $47.72. The Reporting Person, upon request by the Commission Staff, the Issuer or a security holder of the Issuer, undertakes to provide further information regarding the number of securities at each separate price sold. Read SEC document |
| September 03, 2019 Filed Sep 4, 2019 18:38 UTC | LOEWS CORP L · Entity 3231 | Disposition to issuerCommon Stock | 1,089 | $47.68 | $51,923.52 |
DisclosureSEC source: 0001567619-19-017852 · doc1.xml · nonDerivative · entry 2 DIKER CHARLES M · CIK 0000905400 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,048 Read SEC document |
| September 03, 2019 Filed Sep 4, 2019 18:38 UTC | LOEWS CORP L · Entity 3231 | Exercise / conversionCommon Stock | 1,500 | $34.64 | $51,960.00 |
DisclosureSEC source: 0001567619-19-017852 · doc1.xml · nonDerivative · entry 1 DIKER CHARLES M · CIK 0000905400 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,137 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.